Related Experiment Video
Updated: Mar 6, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
Published on: June 4, 2021
Direct Oral Anticoagulants for Venous Thromboembolism: A Pharmacological Review
Joseph C Haley1, Czarina Bock1
1Joseph C. Haley is Clinical Pharmacist, Department of Pharmacy Services, Tampa General Hospital, PO Box 1289, Tampa, FL 33601-1289 (jhaley@tgh.org). Czarina Bock is Clinical Pharmacist, Cardiovascular Services, Department of Pharmacy Services, Tampa General Hospital, Tampa, Florida.
No abstract available in PubMed .
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

